利用人类基因组变异对药物治疗进行个体化Using human genomic variation for individualisation of drug treatment |
|
课程网址: | http://videolectures.net/mdo2014_pirmohamed_drug_treatment/ |
主讲教师: | Munir Pirmohamed |
开课单位: | 利物浦大学 |
开课时间: | 2014-07-21 |
课程语种: | 英语 |
中文简介: | 对药物的反应有内在的差异。这会影响疗效和毒性,这在某些个体中会导致药物的受益风险比很低。通过为个别患者选择合适的药物和合适的剂量来提高药物的受益风险比,从而产生更可预测的药物反应,这是许多研究人员支持的目标,但不幸的是很少实现。药物应答因其性质的不同而具有高度的复杂性,并由疾病的性质(及其亚表型)、遗传因素和环境因素决定。重要的是要考虑到所有这些因素,以优化药物治疗。几十年来,人们对基因组变异产生了极大的兴趣,人类全基因组分析技术的最新进展,包括测序技术,为我们提供了前所未有的能力来审问单个基因组,并将其与药物反应的变异联系起来。这项工作的大部分仍然集中在发现上,但这一点很重要,因为它将揭示可处理的变体,然后可以沿着转化途径进一步进行临床实施。由于许多原因,包括缺乏明确的证据类型指导,以及研究设计不完善,这些发现在这条道路上走得更远,很难推进临床实践。其中一些概念将通过一些关键的例子加以探讨,以借鉴已经采用的战略,这些战略在哪些方面取得了成功,如果没有成功,为什么没有取得成功,以及可以采取哪些措施来改进这一点。 |
课程简介: | There is inherent variation in the responses to drugs used in medicine. This can affect both efficacy and toxicity, which in some individuals leads to a poor benefit-risk ratio of drugs. Strategies to improve the benefit-risk ratio of drugs by choosing the right drug and the right dose for individual patients which leads to more predictable drug responses is an aim that has been espoused by many researchers, but unfortunately rarely achieved. Drug response by its vary nature is highly complex, and is determined by the nature of the disease (and its sub-phenotypes), genetic factors and environmental factors. It is important to take into account all of these factors to optimise drug therapy. There has been a lot of interest in genomic variation for many decades, and the recent advances in technologies for human genome wide analysis, including sequencing technologies, provides us with unprecedented capabilities to interrogate individual genomes and relate this to variation in drug responses. Most of this work is still focused on discovery, but this is important as it will uncover tractable variants which can then be taken further along the translational pathway to clinical implementation. Those discoveries which are further along this pathway have struggled to push into clinical practice for many reasons including the lack of clear guidance as to type of evidence that is needed, and poor study designs. Some of these concepts will be explored using key examples to draw upon strategies that have been adopted, where these have succeeded, and if not, why success has not occurred and what could be done to improve this. |
关 键 词: | 药物; 治疗; 基因组变异 |
课程来源: | 视频讲座网 |
数据采集: | 2020-12-29:yxd |
最后编审: | 2020-12-29:yxd |
阅读次数: | 36 |